How should pneumonia with suspected Legionella or Mycoplasma be managed?

• A. Use a macrolide or doxycycline; consider adding a fluoroquinolone in severe cases; Legionella typically requires a macrolide or a fluoroquinolone.
• B. Always treat with beta-lactams only.
• C. Avoid antibiotics unless confirmed Legionella.
• D. Use vancomycin as first-line.

Answer: (A)

When pneumonia is suspected to be caused by atypical organisms like Legionella or Mycoplasma, the key idea is to use antibiotics that can reach and act inside host cells where these pathogens reside. Macrolides (for example, azithromycin) and doxycycline are effective because they achieve good intracellular concentrations and cover these atypicals. In more severe illness, adding a fluoroquinolone (such as levofloxacin or moxifloxacin) provides broader intracellular activity and helps ensure robust coverage of Legionella. Beta-lactam antibiotics, which target the bacterial cell wall, often don’t reliably treat atypical pathogens, especially Mycoplasma (which lacks a cell wall) and Legionella (an intracellular organism). That’s why monotherapy with beta-lactams isn’t sufficient in this scenario.

The approach described—starting with a macrolide or doxycycline and escalating with a fluoroquinolone in severe cases—best fits the need to cover atypical organisms early, rather than waiting for confirmation. Vancomycin is not first-line for community-acquired pneumonia and does not target these atypicals well. Treating only after a confirmed Legionella diagnosis would miss timely coverage for likely atypical pathogens in many cases.